SM-Youtube

select

Gitto SB, Ihewulezi CJN, Powell DJ Jr. Adoptive T cell therapy for ovarian cancer. Gynecol Oncol. 2024 Jul;186:77-84. doi: 10.1016/j.ygyno.2024.04.001. Epub 2024 Apr 10. Review. PubMed PMID: 38603955; PubMed Central PMCID: PMC11216867.

select

Rempert AN, Rempert TH, Liu A, Hernández A, Blanck J, Segars J, Singh B. A Systematic Review of the Psychosocial Impact of Endometriosis before and after Treatment. Reprod Sci. 2024 Jul;31(7):1828-1860. doi: 10.1007/s43032-024-01515-w. Epub 2024 Mar 21. PubMed PMID: 38512699; PubMed Central PMCID: PMC11216884.

select

Traylor A, Lee PW, Hsieh K, Wang TH. Improving bacteria identification from digital melt assay via oligonucleotide-based temperature calibration. Anal Chim Acta. 2024 Apr 8;1297:342371. doi: 10.1016/j.aca.2024.342371. Epub 2024 Feb 17. PubMed PMID: 38438240; PubMed Central PMCID: PMC11082877.

select

Bedrick BS, Courtright L, Zhang J, Snow M, Amendola ILS, Nylander E, Cayton-Vaught K, Segars J, Singh B. A Systematic Review of Epigenetics of Endometriosis. F S Rev. 2024 Jan;5(1). doi: 10.1016/j.xfnr.2024.01.003. Epub 2024 Feb 2. PubMed PMID: 38524912; PubMed Central PMCID: PMC10956470.

select

Taylor MS, Wu C, Fridy PC, Zhang SJ, Senussi Y, Wolters JC, Cajuso T, Cheng WC, Heaps JD, Miller BD, Mori K, Cohen L, Jiang H, Molloy KR, Chait BT, Goggins MG, Bhan I, Franses JW, Yang X, Taplin ME, Wang X, Christiani DC, Johnson BE, Meyerson M, Uppaluri R, Egloff AM, Denault EN, Spring LM, Wang TL, Shih IM, Fairman JE, Jung E, Arora KS, Yilmaz OH, Cohen S, Sharova T, Chi G, Norden BL, Song Y, Nieman LT, Pappas L, Parikh AR, Strickland MR, Corcoran RB, Mustelin T, Eng G, Yilmaz ÖH, Matulonis UA, Chan AT, Skates SJ, Rueda BR, Drapkin R, Klempner SJ, Deshpande V, Ting DT, Rout MP, LaCava J, Walt DR, Burns KH. Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker. Cancer Discov. 2023 Dec 12;13(12):2532-2547. doi: 10.1158/2159-8290.CD-23-0313. PubMed PMID: 37698949; PubMed Central PMCID: PMC10773488.

select

Hippen AA, Omran DK, Weber LM, Jung E, Drapkin R, Doherty JA, Hicks SC, Greene CS. Performance of computational algorithms to deconvolve heterogeneous bulk ovarian tumor tissue depends on experimental factors. Genome Biol. 2023 Oct 20;24(1):239. doi: 10.1186/s13059-023-03077-7. PubMed PMID: 37864274; PubMed Central PMCID: PMC10588129.

select

Andriani L, Oh J, McMinn E, Gleason E, Koelper NC, Chittams J, Simpkins F, Ko EM. Telehealth utilization in gynecologic oncology clinical trials. Gynecol Oncol. 2023 Oct;177:103-108. doi: 10.1016/j.ygyno.2023.08.011. Epub 2023 Aug 31. PubMed PMID: 37659265; PubMed Central PMCID: PMC10591867.

select

Grisham RN, Slomovitz BM, Andrews N, Banerjee S, Brown J, Carey MS, Chui H, Coleman RL, Fader AN, Gaillard S, Gourley C, Sood AK, Monk BJ, Moore KN, Ray-Coquard I, Shih IM, Westin SN, Wong KK, Gershenson DM. Low-grade serous ovarian cancer: expert consensus report on the state of the science. Int J Gynecol Cancer. 2023 Sep 4;33(9):1331-1344. doi: 10.1136/ijgc-2023-004610. PubMed PMID: 37591609; PubMed Central PMCID: PMC10511962.

select

Yu ZC, Li T, Tully E, Huang P, Chen CN, Oberdoerffer P, Gaillard S, Shih IM, Wang TL. Temozolomide Sensitizes ARID1A-Mutated Cancers to PARP Inhibitors. Cancer Res. 2023 Aug 15;83(16):2750-2762. doi: 10.1158/0008-5472.CAN-22-3646. PubMed PMID: 37306706; PubMed Central PMCID: PMC10527942.

select

Wethington SL, Shah PD, Martin L, Tanyi JL, Latif N, Morgan M, Torigian DA, Rodriguez D, Smith SA, Dean E, Domchek SM, Drapkin R, Shih IM, Brown EJ, Hwang WT, Armstrong DK, Gaillard S, Giuntoli R, Simpkins F. Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor-Resistant Homologous Recombination-Deficient Ovarian Cancer. Clin Cancer Res. 2023 Aug 1;29(15):2800-2807. doi: 10.1158/1078-0432.CCR-22-2444. PubMed PMID: 37097611.

select

Zhao Y, O'Keefe CM, Hsieh K, Cope L, Joyce SC, Pisanic TR, Herman JG, Wang TH. Multiplex Digital Methylation-Specific PCR for Noninvasive Screening of Lung Cancer. Adv Sci (Weinh). 2023 Jun;10(16):e2206518. doi: 10.1002/advs.202206518. Epub 2023 Apr 11. PubMed PMID: 37039321; PubMed Central PMCID: PMC10238189.

select

Shao F, Park JS, Zhao G, Hsieh K, Wang TH. Elucidating the Role of CRISPR/Cas in Single-Step Isothermal Nucleic Acid Amplification Testing Assays. Anal Chem. 2023 Feb 21;95(7):3873-3882. doi: 10.1021/acs.analchem.2c05632. Epub 2023 Feb 6. PubMed PMID: 36745596; PubMed Central PMCID: PMC10884613.

select

Vistein R, Winer B, Myers S, Liberto J, Ishiyama S, Guo X, Saeki H, Wang TL, Shih IM, Gabrielson K. Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice. J Vis Exp. 2023 Feb 17;(192). doi: 10.3791/64732. PubMed PMID: 36876944.

select

Asaka S, Liu Y, Yu ZC, Rahmanto YS, Ono M, Asaka R, Miyamoto T, Yen TT, Ayhan A, Wang TL, Shih IM. ARID1A Regulates Progesterone Receptor Expression in Early Endometrial Endometrioid Carcinoma Pathogenesis. Mod Pathol. 2023 Feb;36(2):100045. doi: 10.1016/j.modpat.2022.100045. Epub 2023 Jan 10. PubMed PMID: 36853791.

select

Shao F, Lee PW, Li H, Hsieh K, Wang TH. Emerging platforms for high-throughput enzymatic bioassays. Trends Biotechnol. 2023 Jan;41(1):120-133. doi: 10.1016/j.tibtech.2022.06.006. Epub 2022 Jul 18. Review. PubMed PMID: 35863950; PubMed Central PMCID: PMC9789168.

select

Wang Y, Huang P, Wang BG, Murdock T, Cope L, Hsu FC, Wang TL, Shih IM. Spatial Transcriptomic Analysis of Ovarian Cancer Precursors Reveals Reactivation of IGFBP2 during Pathogenesis. Cancer Res. 2022 Dec 16;82(24):4528-4541. doi: 10.1158/0008-5472.CAN-22-1620. PubMed PMID: 36206311; PubMed Central PMCID: PMC9808976.

select

Vang R, Shih IM. Serous tubal intra-epithelial carcinoma: what do we really know at this point?. Histopathology. 2022 Nov;81(5):542-555. doi: 10.1111/his.14722. Epub 2022 Aug 4. Review. PubMed PMID: 35859323.

select

Hong J, Shen YA, Hsu CY, Huang P, Tomaszewski A, Gabrielson E, Shih IM, Gaillard S, Wang TL. Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC). Genes Dis. 2022 Nov;9(6):1408-1411. doi: 10.1016/j.gendis.2022.02.009. eCollection 2022 Nov. PubMed PMID: 36157486; PubMed Central PMCID: PMC9485268.

select

Mandal J, Mandal P, Wang TL, Shih IM. Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response. J Biomed Sci. 2022 Sep 19;29(1):71. doi: 10.1186/s12929-022-00856-5. Review. PubMed PMID: 36123603; PubMed Central PMCID: PMC9484255.

select

Huang P, Illei PB, Franklin W, Wu PH, Forde PM, Ashrafinia S, Hu C, Khan H, Vadvala HV, Shih IM, Battafarano RJ, Jacobs MA, Kong X, Lewis J, Yan R, Chen Y, Housseau F, Rahmim A, Fishman EK, Ettinger DS, Pienta KJ, Wirtz D, Brock MV, Lam S, Gabrielson E. Lung Cancer Recurrence Risk Prediction through Integrated Deep Learning Evaluation. Cancers (Basel). 2022 Aug 27;14(17). doi: 10.3390/cancers14174150. PubMed PMID: 36077686; PubMed Central PMCID: PMC9454871.

select

Liu H, Lin J, Zhou W, Moses R, Dai Z, Kossenkov AV, Drapkin R, Bitler BG, Karakashev S, Zhang R. KDM5A Inhibits Antitumor Immune Responses Through Downregulation of the Antigen-Presentation Pathway in Ovarian Cancer. Cancer Immunol Res. 2022 Aug 3;10(8):1028-1038. doi: 10.1158/2326-6066.CIR-22-0088. PubMed PMID: 35726891; PubMed Central PMCID: PMC9357105.

select

Liberto JM, Chen SY, Shih IM, Wang TH, Wang TL, Pisanic TR 2nd. Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review. Cancers (Basel). 2022 Jun 11;14(12). doi: 10.3390/cancers14122885. Review. PubMed PMID: 35740550; PubMed Central PMCID: PMC9221480.

select

Chaves-Moreira D, Mitchell MA, Arruza C, Rawat P, Sidoli S, Nameki R, Reddy J, Corona RI, Afeyan LK, Klein IA, Ma S, Winterhoff B, Konecny GE, Garcia BA, Brady DC, Lawrenson K, Morin PJ, Drapkin R. The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17. Sci Signal. 2022 Apr 5;15(728):eabm2496. doi: 10.1126/scisignal.abm2496. Epub 2022 Apr 5. PubMed PMID: 35380877; PubMed Central PMCID: PMC9135381.

select

Stephens VR, Rumph JT, Ameli S, Bruner-Tran KL, Osteen KG. The Potential Relationship Between Environmental Endocrine Disruptor Exposure and the Development of Endometriosis and Adenomyosis. Front Physiol. 2021;12:807685. doi: 10.3389/fphys.2021.807685. eCollection 2021. Review. PubMed PMID: 35153815; PubMed Central PMCID: PMC8832054.

select

Rumph JT, Stephens VR, Martin JL, Brown LK, Thomas PL, Cooley A, Osteen KG, Bruner-Tran KL. Uncovering Evidence: Associations between Environmental Contaminants and Disparities in Women's Health. Int J Environ Res Public Health. 2022 Jan 23;19(3). doi: 10.3390/ijerph19031257. Review. PubMed PMID: 35162279; PubMed Central PMCID: PMC8835285.

select

Eiva MA, Omran DK, Chacon JA, Powell DJ Jr. Systematic analysis of CD39, CD103, CD137, and PD-1 as biomarkers for naturally occurring tumor antigen-specific TILs. Eur J Immunol. 2022 Jan;52(1):96-108. doi: 10.1002/eji.202149329. Epub 2021 Sep 18. PubMed PMID: 34505280; PubMed Central PMCID: PMC8755575.

select

Cunningham JM, Winham SJ, Wang C, Weiglt B, Fu Z, Armasu SM, McCauley BM, Brand AH, Chiew YE, Elishaev E, Gourley C, Kennedy CJ, Laslavic A, Lester J, Piskorz A, Sekowska M, Brenton JD, Churchman M, DeFazio A, Drapkin R, Elias KM, Huntsman DG, Karlan BY, Köbel M, Konner J, Lawrenson K, Papaemmanuil E, Bolton KL, Modugno F, Goode EL. DNA Methylation Profiles of Ovarian Clear Cell Carcinoma. Cancer Epidemiol Biomarkers Prev. 2022 Jan;31(1):132-141. doi: 10.1158/1055-9965.EPI-21-0677. Epub 2021 Oct 25. PubMed PMID: 34697060; PubMed Central PMCID: PMC8755592.

select

Lin J, Guo D, Liu H, Zhou W, Wang C, Müller I, Kossenkov AV, Drapkin R, Bitler BG, Helin K, Zhang R. The SETDB1-TRIM28 Complex Suppresses Antitumor Immunity. Cancer Immunol Res. 2021 Dec;9(12):1413-1424. doi: 10.1158/2326-6066.CIR-21-0754. PubMed PMID: 34848497; PubMed Central PMCID: PMC8647838.

select

Li L, Antero MF, Zhang M, Chu T, Seckin T, Ayhan A, Pisanic T, Wang TL, Cope L, Segars J, Shih IM. Mutation and methylation profiles of ectopic and eutopic endometrial tissues. J Pathol. 2021 Dec;255(4):387-398. doi: 10.1002/path.5778. Epub 2021 Sep 20. PubMed PMID: 34396532; PubMed Central PMCID: PMC9808974.

select

Shen YA, Jung J, Shimberg GD, Hsu FC, Rahmanto YS, Gaillard SL, Hong J, Bosch J, Shih IM, Chuang CM, Wang TL. Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategy. iScience. 2021 Nov 19;24(11):103297. doi: 10.1016/j.isci.2021.103297. eCollection 2021 Nov 19. PubMed PMID: 34816098; PubMed Central PMCID: PMC8591422.

select

Shah PD, Wethington SL, Pagan C, Latif N, Tanyi J, Martin LP, Morgan M, Burger RA, Haggerty A, Zarrin H, Rodriguez D, Domchek S, Drapkin R, Shih IM, Smith SA, Dean E, Gaillard S, Armstrong D, Torigian DA, Hwang WT, Giuntoli R, Simpkins F. Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer. Gynecol Oncol. 2021 Nov;163(2):246-253. doi: 10.1016/j.ygyno.2021.08.024. Epub 2021 Oct 5. PubMed PMID: 34620496; PubMed Central PMCID: PMC9614917.

select

Park Y, Jung JG, Yu ZC, Asaka R, Shen W, Wang Y, Jung WH, Tomaszewski A, Shimberg G, Chen Y, Parimi V, Gaillard S, Shih IM, Wang TL. A novel human endometrial epithelial cell line for modeling gynecological diseases and for drug screening. Lab Invest. 2021 Nov;101(11):1505-1512. doi: 10.1038/s41374-021-00624-3. Epub 2021 Aug 10. PubMed PMID: 34376780; PubMed Central PMCID: PMC8720294.

select

Zundell JA, Fukumoto T, Lin J, Fatkhudinov N, Nacarelli T, Kossenkov AV, Liu Q, Cassel J, Hu CA, Wu S, Zhang R. Targeting the IRE1α/XBP1 Endoplasmic Reticulum Stress Response Pathway in ARID1A-Mutant Ovarian Cancers. Cancer Res. 2021 Oct 15;81(20):5325-5335. doi: 10.1158/0008-5472.CAN-21-1545. Epub 2021 Sep 21. PubMed PMID: 34548333; PubMed Central PMCID: PMC8723353.

select

Ferriss JS, Erickson BK, Shih IM, Fader AN. Uterine serous carcinoma: key advances and novel treatment approaches. Int J Gynecol Cancer. 2021 Aug;31(8):1165-1174. doi: 10.1136/ijgc-2021-002753. Epub 2021 Jul 1. Review. PubMed PMID: 34210768.

select

Cordova R, Kiekens K, Burrell S, Drake W, Kmeid Z, Rice P, Rocha A, Diaz S, Yamada S, Yozwiak M, Nelson OL, Rodriguez GC, Heusinkveld J, Shih IM, Alberts DS, Barton JK. Sub-millimeter endoscope demonstrates feasibility of in vivo reflectance imaging, fluorescence imaging, and cell collection in the fallopian tubes. J Biomed Opt. 2021 Jul;26(7). doi: 10.1117/1.JBO.26.7.076001. PubMed PMID: 34216135; PubMed Central PMCID: PMC8253554.

select

Peng D, Gleyzer R, Tai WH, Kumar P, Bian Q, Isaacs B, da Rocha EL, Cai S, DiNapoli K, Huang FW, Cahan P. Evaluating the transcriptional fidelity of cancer models. Genome Med. 2021 Apr 29;13(1):73. doi: 10.1186/s13073-021-00888-w. PubMed PMID: 33926541; PubMed Central PMCID: PMC8086312.

select

Hippen AA, Greene CS. Expanding and Remixing the Metadata Landscape. Trends Cancer. 2021 Apr;7(4):276-278. doi: 10.1016/j.trecan.2020.10.011. Epub 2020 Nov 20. Review. PubMed PMID: 33229213; PubMed Central PMCID: PMC8324015.

select

Karakashev S, Zhang RG. Mouse models of epithelial ovarian cancer for preclinical studies. Zool Res. 2021 Mar 18;42(2):153-160. doi: 10.24272/j.issn.2095-8137.2020.382. Review. PubMed PMID: 33527800; PubMed Central PMCID: PMC7995272.

select

Chaves-Moreira D, Morin PJ, Drapkin R. Unraveling the Mysteries of PAX8 in Reproductive Tract Cancers. Cancer Res. 2021 Feb 15;81(4):806-810. doi: 10.1158/0008-5472.CAN-20-3173. Epub 2020 Dec 23. Review. PubMed PMID: 33361393; PubMed Central PMCID: PMC8026505.

select

Wu S, Fukumoto T, Lin J, Nacarelli T, Wang Y, Ong D, Liu H, Fatkhutdinov N, Zundell JA, Karakashev S, Zhou W, Schwartz LE, Tang HY, Drapkin R, Liu Q, Huntsman DG, Kossenkov AV, Speicher DW, Schug ZT, Van Dang C, Zhang R. Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma. Nat Cancer. 2021 Feb;2(2):189-200. doi: 10.1038/s43018-020-00160-x. Epub 2021 Jan 11. PubMed PMID: 34085048; PubMed Central PMCID: PMC8168620.

select

Shih IM, Wang Y, Wang TL. The Origin of Ovarian Cancer Species and Precancerous Landscape. Am J Pathol. 2021 Jan;191(1):26-39. doi: 10.1016/j.ajpath.2020.09.006. Epub 2020 Oct 1. Review. PubMed PMID: 33011111; PubMed Central PMCID: PMC7786078.

select

Fan H, Atiya HI, Wang Y, Pisanic TR, Wang TH, Shih IM, Foy KK, Frisbie L, Buckanovich RJ, Chomiak AA, Tiedemann RL, Rothbart SB, Chandler C, Shen H, Coffman LG. Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis. Cell Rep. 2020 Dec 8;33(10):108473. doi: 10.1016/j.celrep.2020.108473. PubMed PMID: 33296650; PubMed Central PMCID: PMC7747301.

select

Reavis HD, Chen HI, Drapkin R. Tumor Innervation: Cancer Has Some Nerve. Trends Cancer. 2020 Dec;6(12):1059-1067. doi: 10.1016/j.trecan.2020.07.005. Epub 2020 Aug 14. Review. PubMed PMID: 32807693; PubMed Central PMCID: PMC7688507.

select

Pisanic TR 2nd, Wang Y, Sun H, Considine M, Li L, Wang TH, Wang TL, Shih IM. Methylomic Landscapes of Ovarian Cancer Precursor Lesions. Clin Cancer Res. 2020 Dec 1;26(23):6310-6320. doi: 10.1158/1078-0432.CCR-20-0270. Epub 2020 Aug 17. PubMed PMID: 32817081; PubMed Central PMCID: PMC7710556.

select

Antero MF, Ayhan A, Segars J, Shih IM. Pathology and Pathogenesis of Adenomyosis. Semin Reprod Med. 2020 May;38(2-03):108-118. doi: 10.1055/s-0040-1718922. Epub 2020 Oct 20. Review. PubMed PMID: 33080632; PubMed Central PMCID: PMC7987203.

select

Shen YA, Hong J, Asaka R, Asaka S, Hsu FC, Suryo Rahmanto Y, Jung JG, Chen YW, Yen TT, Tomaszewski A, Zhang C, Attarwala N, DeMarzo AM, Davidson B, Chuang CM, Chen X, Gaillard S, Le A, Shih IM, Wang TL. Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers. Cancer Res. 2020 Oct 15;80(20):4514-4526. doi: 10.1158/0008-5472.CAN-19-3971. Epub 2020 Aug 28. PubMed PMID: 32859605; PubMed Central PMCID: PMC7572606.

select

Islam MS, Afrin S, Jones SI, Segars J. Selective Progesterone Receptor Modulators-Mechanisms and Therapeutic Utility. Endocr Rev. 2020 Oct 1;41(5). doi: 10.1210/endrev/bnaa012. Review. PubMed PMID: 32365199; PubMed Central PMCID: PMC8659360.

select

Valle BL, Rodriguez-Torres S, Kuhn E, Díaz-Montes T, Parrilla-Castellar E, Lawson FP, Folawiyo O, Ili-Gangas C, Brebi-Mieville P, Eshleman JR, Herman J, Shih IM, Sidransky D, Guerrero-Preston R. HIST1H2BB and MAGI2 Methylation and Somatic Mutations as Precision Medicine Biomarkers for Diagnosis and Prognosis of High-grade Serous Ovarian Cancer. Cancer Prev Res (Phila). 2020 Sep;13(9):783-794. doi: 10.1158/1940-6207.CAPR-19-0412. Epub 2020 Jun 24. PubMed PMID: 32581010; PubMed Central PMCID: PMC8082233.

select

Qu H, Li L, Wang TL, Seckin T, Segars J, Shih IM. Epithelial Cells in Endometriosis and Adenomyosis Upregulate STING Expression. Reprod Sci. 2020 Jun;27(6):1276-1284. doi: 10.1007/s43032-019-00127-z. Epub 2020 Jan 6. PubMed PMID: 32046461; PubMed Central PMCID: PMC7539849.

select

Reavis HD, Drapkin R. The tubal epigenome - An emerging target for ovarian cancer. Pharmacol Ther. 2020 Jun;210:107524. doi: 10.1016/j.pharmthera.2020.107524. Epub 2020 Mar 18. Review. PubMed PMID: 32197795; PubMed Central PMCID: PMC7237289.